Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations

British Journal of Cancer

Volumn 79, Issue 7-8, 1999, Pages 1139-1144

  Nakagawa, S ^a   Yoshikawa, H ^a   Jimbo, H ^a   Onda, T ^a   Yasugi, T ^a   Matsumoto, K ^a   Kino, N ^a   Kawana, K ^a   Kozuka, T ^a   Nakagawa, K ^a   Aoki, M ^a   Taketani, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cervical carcinoma; Elderly women; Human papillomavirus; p53 mutation

Indexed keywords

DNA; PROTEIN P53;

AGED; ARTICLE; DNA SEQUENCE; FEMALE; GENE MUTATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; UTERINE CERVICAL NEOPLASMS;

EID: 0033023408     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690181     Document Type: Article

References (33)

1. Cho Y, Gorina S, Jeffrey PD and Pavletich NP (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355
2. Choo KB and Chong KY (1993) Absence of mutation in the p53 and retinoblastoma susceptibility genes in primary cervical carcinomas. Virology 193: 1042-1046
3. Crook T and Vousden KH (1992) Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J 11: 3935-3940
4. Crook T, Wrede D and Vousden KH (1991) p53 point mutation in HPV-negative human cervical carcinoma cell lines. Oncogene 6: 873-875
5. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ (1993) Gain of function mutation of p53. Nature Genet 4: 42-46
6. Fujinaga Y, Shimada M, Okazawa K, Fukushima M, Kato I and Fujinaga K (1991) Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 72: 1039-1044
7. Fujita M, Inoue M, Tanizawa O, Iwamoto S and Enomoto T (1992) Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 52: 5323-5328
8. Harris CC (1993) p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 262: 1980-1981
9. Helland A, Holm R, Kristensen G, Laern J, Kaern J, Karlsen F, Trope C, Nesland JM and Borresen AL (1993) Genetic alterations of the p53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. J Path 171: 105-114
10. Huibregtse JM, Scheffner M and Howley PM (1993) Cloning and expression of the cDNA lor E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 13: 775-784
11. Kagie MJ, Kenter GG, Tollenaar RAEM, Hermans J, Trimbos JB and Fleuren GJ (1997) p53 protein overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva. Cancer 80: 1228-1233
12. Kanda T, Watanabe S and Yoshiike K (1988) Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragment controlled by SV40 promoter. Virology 165: 321-325
13. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7495
14. Lechner MS and Laimins LA (1994) Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J Virol 68: 4262-4293
15. Lee YY, Wilczynski P, Chumakov A, Chih D and Loeffler HP (1994) Carcinoma of the vulva: HPV and p53 mutations. Oncogene 9: 1655-1659
16. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W and Kurman RJ (1992) Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 79: 328-337
17. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
18. Milde-Langosch KM, Albrecht K, Joram S, Schlechte H, Giessing M and Loning T (1995) Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer 63: 639-645
19. Miwa K, Miyamoto S, Imamura T, Nishida M, Yoshikawa Y, Nagata Y and Wake N (1995) The role of p53 inactivation in human cervical cell carcinoma development. Br J Cancer 71: 219-226
20. Munger K, Phelps WC, Bubb V, Howley PM and Schlegel R (1989a) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63: 4417-4421
21. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E and Howley PM (1989b) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8: 4099-4105
22. Nagano H, Yoshikawa H, Kawana T, Yokota H, Taketani Y, Igarashi H, Yoshikura H and Iwamoto A (1996) Association of multiple human papillomavirus types with vulvar neoplasias. J Obstet Gynecol Res 22: 1-8
23. Naito M, Satake M, Sakai E, Hirano Y, Tsuchida N, Kanzaki H, Ito Y and Mori T (1992) Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis. Jpn J Cancer Res 83: 1030-1036
24. Nakagawa S, Watanabe S, Yoshikawa H, Taketani Y, Yoshiike K and Kanda T (1995) Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro. Virology 212: 535-542
25. Nakagawa S, Yoshikawa H, Onda T, Kawana T, Iwamoto A and Taketani Y (1996) Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer 78: 1935-1941
26. Nevins JR (1992) E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-429
27. Paquette RL, Lee YY, Wilczynski SP, Karmakar A, Kizaki M, Miller CW and Koeffler HP (1993) Mutation of p53 and human papillomavirus infection in cervical carcinoma. Cancer 72: 1272-1280
28. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136
29. Snijders PJF, Van den Brule AJC, Schrijnemakers HFJ, Snow G, Meijer CJLM and Walboomers JMM (1990) The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 17: 173-181
30. Storey A, Pim D, Murray A, Osborn K, Banks L and Crawford L (1988) Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J 7: 1815-1820
31. van Ravenswaay Claasen HH, Kluin PM and Fleuren GJ (1992). Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in anti-tumor cytotoxicity. Lab Invest 67: 166-174
32. Werness BA, Levine AJ and Howley PM (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79
33. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H and Iwamoto A (1991) Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 82: 524-531